These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38856143)

  • 1. Sex differences in the global burden of multidrug- resistant tuberculosis without extensive drug resistance in the general population and people living with HIV/AIDS, 1990-2019.
    Choi J; Park J; Son Y; Kim S; Kwon R; Lee H; Rahmati M; Kang J; Woo HG; Koyanagi A; Smith L; López Sánchez GF; Dragioti E; Lee SH; Cho W; Kim HJ; Shin JI; Yon DK
    Eur Rev Med Pharmacol Sci; 2024 May; 28(10):3669-3682. PubMed ID: 38856143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological features and temporal trends of the co-infection between HIV and tuberculosis, 1990-2021: findings from the Global Burden of Disease Study 2021.
    Zhang SX; Wang JC; Yang J; Lv S; Duan L; Lu Y; Tian LG; Chen MX; Liu Q; Wei FN; Feng XY; Yang GB; Li YJ; Wang Y; Hu XJ; Yang M; Lu ZH; Zhang SY; Li SZ; Zheng JX
    Infect Dis Poverty; 2024 Aug; 13(1):59. PubMed ID: 39152514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global trends, regional differences and age distribution for the incidence of HIV and tuberculosis co-infection from 1990 to 2019: results from the global burden of disease study 2019.
    Wang Y; Jing W; Liu J; Liu M
    Infect Dis (Lond); 2022 Nov; 54(11):773-783. PubMed ID: 35801264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990-2019: results from the Global Burden of Disease Study 2019.
    GBD 2019 Tuberculosis Collaborators
    Lancet Infect Dis; 2022 Feb; 22(2):222-241. PubMed ID: 34563275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global burden of MDR-TB and XDR-TB attributable to high fasting plasma glucose from 1990 to 2019: a retrospective analysis based on the global burden of disease study 2019.
    Chen Y; Liu J; Zhang Q; Chen H; Chai L; Wang Y; Zhang J; Qiu Y; Shen N; Shi X; Wang Q; Wang J; Li S; Li M
    Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):747-765. PubMed ID: 38367094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global, regional, and national burden of HIV-negative tuberculosis, 1990-2021: findings from the Global Burden of Disease Study 2021.
    Zhang SX; Miao FY; Yang J; Zhou WT; Lv S; Wei FN; Wang Y; Hu XJ; Yin P; Zheng PY; Yang M; Wang MT; Feng XY; Duan L; Yang GB; Wang JC; Lu ZH
    Infect Dis Poverty; 2024 Aug; 13(1):60. PubMed ID: 39155365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Tuberculosis Collaborators
    Lancet Infect Dis; 2024 Jul; 24(7):698-725. PubMed ID: 38518787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV and tuberculosis co-infection in East Asia and the Pacific from 1990 to 2017: results from the Global Burden of Disease Study 2017.
    Zhang J; Kern-Allely S; Yu T; Price RK
    J Thorac Dis; 2019 Sep; 11(9):3822-3835. PubMed ID: 31656655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global prevalence and burden of multidrug-resistant tuberculosis from 1990 to 2019.
    Lv H; Zhang X; Zhang X; Bai J; You S; Li X; Li S; Wang Y; Zhang W; Xu Y
    BMC Infect Dis; 2024 Feb; 24(1):243. PubMed ID: 38388352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting.
    Vella V; Racalbuto V; Guerra R; Marra C; Moll A; Mhlanga Z; Maluleke M; Mhlope H; Margot B; Friedland G; Shah NS; Gandhi NR
    Int J Tuberc Lung Dis; 2011 Sep; 15(9):1170-5, i. PubMed ID: 21943840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
    van Maaren PJ
    Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological features and temporal trends of HIV-negative tuberculosis burden from 1990 to 2019: a retrospective analysis based on the Global Burden of Disease Study 2019.
    Chen Y; Liu J; Zhang Q; Wang Q; Chai L; Chen H; Li D; Qiu Y; Wang Y; Shen N; Wang J; Xie X; Li S; Li M
    BMJ Open; 2023 Sep; 13(9):e074134. PubMed ID: 37770275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting.
    Gandhi NR; Andrews JR; Brust JC; Montreuil R; Weissman D; Heo M; Moll AP; Friedland GH; Shah NS
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):90-7. PubMed ID: 22236852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensively drug-resistant tuberculosis in the United States, 1993-2007.
    Shah NS; Pratt R; Armstrong L; Robison V; Castro KG; Cegielski JP
    JAMA; 2008 Nov; 300(18):2153-60. PubMed ID: 19001626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India.
    Sethi S; Mewara A; Dhatwalia SK; Singh H; Yadav R; Singh K; Gupta D; Wanchu A; Sharma M
    BMC Infect Dis; 2013 Mar; 13():137. PubMed ID: 23497169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug resistant tuberculosis].
    Zwolska Z; Augustynowicz-Kopeć E
    Pol Merkur Lekarski; 2011 May; 30(179):362-6. PubMed ID: 21675144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions.
    Prasad R
    Indian J Tuberc; 2010 Oct; 57(4):180-91. PubMed ID: 21141336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community.
    Andrews JR; Shah NS; Weissman D; Moll AP; Friedland G; Gandhi NR
    PLoS One; 2010 Dec; 5(12):e15735. PubMed ID: 21209951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
    Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
    J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.